Accelerate your orphan drug development for rare diseases

At Quotient Sciences we have supported over 50 development programs for rare diseases in the past 5 years. Our extensive formulation know-how, and clinical pharmacology expertise, coupled with our agile and flexible approach to clinical manufacturing and commercial manufacturing, make us the ideal partner.

From pre-formulation and formulation development through clinical development and scale-up for commercial manufacturing, we provide an end-to-end solution for the development of orphan drug products. Our extensive expertise and capabilities for orphan drug development include:

• Pre-formulation and API characterisation.
• Formulation and process development.
• First-in-human clinical testing and acceleration into POC trials.
• Bespoke clinical manufacturing and supply (Phase I-III) of drug products into patient trials.
• Rapid scale-up and commercial manufacturing of low-volume products.